Gaumard Scientific vice president Jim Archetto said the goal is to place providers into the kind of “low-frequency, high-risk” environment they might not often encounter in a clinical setting. Despite medical and technological advancements, the United States has continued to face a maternal health crisis. In fact, the rate of maternal mortality has been increasing in […]

EXECUTIVE SUMMARY Results of recent research show a direct correlation between simulator training for OB/GYNs and a reduction in medical malpractice claim rates. Claim rates declined from 11.2 claims per 100 physician coverage years before simulation training to 5.7 claims. Similar effectiveness can be expected from simulation training in other areas of medicine. A simulation […]

Dr. Kleanthis Xanthopoulos, co-founder,  Chairman  and CEO of Shoreline Biosciences, discusses the development of genetically engineered induced pluripotent stem cell (iPSC)-derived allogeneic natural killer (NK) and macrophage products that are intelligently designed for greater  specificity, potency and persistence, overcoming the limitations of early cell therapies, for use in oncology and regenerative medicine. Kleanthis is a serial […]